Agios Pharmaceuticals Inc (AGIO) Event Aug. 04, 2022, 00:00 UTC (80% Positive) AGIOS PHARMACEUTICALS, INC. (AGIO) Reports 1058% Profit Growth for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 11:03 a.m. 🏢 Agios Pharmaceuticals Inc (AGIO) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-04 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $1.79B $-186.58M $1.97B +1058.36% 📉 Total Assets $1.44B $1.25B $185.27M +14.79% 📈 Total Liabilities $145.76M $128.40M $17.36M +13.52% 📉 Stockholders' Equity $1.72B $-529.05M $2.25B +425.46% 📈 Operating Income/Loss $-182.44M $-198.78M $16.35M +8.22% 📉 R&D Expense $119.67M $144.65M $-24.97M -17.26% 📈 Earningspersharebasic $27.39 $-3.41 $30.80 +903.23% 📈 Earningspersharediluted $27.39 $-3.41 $30.80 +903.23% 📈 📈 Financial Trend Analysis 💰 Profitability improved with +1058.4% net income growth • 🏦 Strengthened balance sheet with assets growing faster than liabilities 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Agios Pharmaceuticals Inc (AGIO) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
💰 Profitability improved with +1058.4% net income growth • 🏦 Strengthened balance sheet with assets growing faster than liabilities
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document